4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Prevalence of Central Vein Stenosis in Patients Referred for Vein Mapping

      , , ,
      Clinical Journal of the American Society of Nephrology
      American Society of Nephrology (ASN)

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="d8796018e165"> <!-- named anchor --> </a> <h5 class="section-title" id="d8796018e166">Background and objectives</h5> <p id="d8796018e168">Central vein stenosis is considered to be common in patients on hemodialysis but its exact prevalence is not known. In this study, we report the prevalence of central vein stenosis in patients with CKD referred for vein mapping. </p> </div><div class="section"> <a class="named-anchor" id="d8796018e170"> <!-- named anchor --> </a> <h5 class="section-title" id="d8796018e171">Design, setting, participants, &amp; measurements</h5> <p id="d8796018e173">We conducted a retrospective study of adult patients who had bilateral upper extremity venographic vein mapping from September 1, 2011 to December 31, 2015. Patients with and without stenosis were compared for differences in clinical or demographic characteristics. Multiple logistic regression was used to identify independent associations between patient characteristics and central vein stenosis. </p> </div><div class="section"> <a class="named-anchor" id="d8796018e175"> <!-- named anchor --> </a> <h5 class="section-title" id="d8796018e176">Results</h5> <p id="d8796018e178">There were 525 patients who underwent venographic vein mapping during the study period, 27% of whom were referred before initiation of hemodialysis. The mean age (±SD) and body mass index were 59 (±15) years and 28 (±7), respectively. Women accounted for 45% of patients; 82% were black. The prevalence of central vein stenosis was 10% (95% confidence interval [95% CI], 8% to 13%) for the whole group, and 13% (95% CI, 10% to 17%) among patients with tunneled central venous dialysis catheters. Current use of tunneled hemodialysis catheters (odds ratio [OR], 14.5; 95% CI, 3.25 to 65.1), presence of cardiac rhythm devices (OR, 5.07; 95% CI, 1.82 to 14.11), previous history of fistula or graft (OR, 3.28; 95% CI, 1.58 to 6.7), and history of previous kidney transplant (OR, 18; 95% CI, 4.7 to 68.8) were independently associated with central vein stenosis. </p> </div><div class="section"> <a class="named-anchor" id="d8796018e180"> <!-- named anchor --> </a> <h5 class="section-title" id="d8796018e181">Conclusions</h5> <p id="d8796018e183">In this population, the prevalence of central vein stenosis was 10% and was clustered among those with tunneled hemodialysis catheters, cardiac rhythm device, and previous history of dialysis access or transplant. </p> </div><p class="first" id="d8796018e186"> <div class="fig panel" id="absf1"> <a class="named-anchor" id="absf1"> <!-- named anchor --> </a> <div class="figure-container so-text-align-c"> <img alt="" class="figure" src="/document_file/7e0bf8c7-8e10-487e-b7b6-ec5a30ce8095/PubMedCentral/image/CJN.14001217absf1"/> </div> <div class="panel-content"/> </div> </p>

          Related collections

          Most cited references29

          • Record: found
          • Abstract: not found
          • Article: not found

          Clinical practice guidelines for vascular access.

          (2006)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators.

            Sudden cardiac death is the single largest cause of mortality in dialysis patients. There are no published data on the use or survival impact of implantable cardioverter defibrillators (ICDs) in dialysis patients. The objective of this retrospective cohort study was to determine ICD use in dialysis patients and impact on survival. Dialysis patients hospitalized from 1996 to 2001 for ventricular fibrillation/cardiac arrest, having ICD implantation within 30 days of admission, discharged alive, and surviving at least 30 days from admission were identified from the 100% end-stage renal disease (ESRD) sample of the Medicare database. Long-term survival was estimated by life-table method. Impact of independent predictors on survival was examined in a comorbidity-adjusted Cox model and a propensity model. There were 460 patients (7.6%) with ICD and 5582 patients (92.4%) without ICD. Estimated 1-, 2-, 3-, 4-, and 5-year survivals after day 30 of admission in the ICD group were 71%, 53%, 36%, 25%, and 22%, respectively; in the no-ICD group, 49%, 33%, 23%, 16%, and 12% (P < 0.0001). ICD implantation was independently associated with a 42% reduction in death risk [relative risk 0.58 (95% CI 0.50, 0.66)]. In the propensity model, the relative risks of death for the lower, middle, and upper third propensity groups were 0.45 (0.26, 0.81), 0.61 (0.45, 0.84), and 0.65 (0.55, 0.76), respectively. The C statistic for the propensity model equaled 0.81. In dialysis patients, ICD therapy is apparently underused. ICD implantation in cardiac arrest survivors on dialysis is associated with greater survival.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Epidemiology of haemodialysis catheter complications: a survey of 865 dialysis patients from 14 haemodialysis centres in Henan province in China

              Objectives To investigate the incidence rates and risk factors for catheter-related complications in different districts and populations in Henan Province in China. Design Cross-sectional. Setting Fourteen hospitals in Henan Province. Participants 865 patients with renal dysfunction undergoing dialysis using catheters between October 2013 and October 2014. Main outcome measures The main outcome measures were complications, risk factors and patient characteristics. Catheter-related complications included catheter-related infection (catheter exit-site infection, catheter tunnel infection and catheter-related bloodstream infection), catheter dysfunction (thrombosis, catheter malposition or kinking, and fibrin shell formation) and central vein stenosis. Results The overall incidence rate was 7.74/1000 catheter-days, affecting 38.61% of all patients, for catheter infections, 10.58/1000 catheter-days, affecting 56.65% of all patients, for catheter dysfunction, and 0.68/1000 catheter-days, affecting 8.79% of all patients, for central vein stenosis. Multivariate analysis showed that increased age, diabetes, primary educational level or below, rural residence, lack of a nephropathy visit before dialysis and pre-established permanent vascular access, not taking oral drugs to prevent catheter thrombus, lower serum albumin levels and higher ferritin levels were independently associated with catheter infections. Rural residence, not taking oral drugs to prevent thrombus, lack of an imaging examination after catheter insertion, non-tunnel catheter type, lack of medical insurance, lack of nephropathy visit before dialysis and pre-established permanent vascular access, left-sided catheter position, access via the femoral vein and lower haemoglobin level were independently associated with catheter dysfunction. Diabetes, lack of nephropathy visit before dialysis and pre-established permanent vascular access, lack of oral drugs to prevent catheter thrombus, left-sided catheter location and higher number of catheter insertions, were independently associated with central vein stenosis. Conclusions The rate of catheter-related complications was high in patients with end-stage renal disease in Henan Province. Our finding suggest that strategies should be implemented to decrease complication rates.
                Bookmark

                Author and article information

                Journal
                Clinical Journal of the American Society of Nephrology
                CJASN
                American Society of Nephrology (ASN)
                1555-9041
                1555-905X
                July 06 2018
                July 06 2018
                July 06 2018
                May 08 2018
                : 13
                : 7
                : 1063-1068
                Article
                10.2215/CJN.14001217
                6032590
                29739749
                59224d35-9a40-47b9-975c-e6a244727dd0
                © 2018
                History

                Comments

                Comment on this article